Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (611-620 of 666) with videos related to

Pageof 67
Sort By:
Nature Medicine|October 25, 2024
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trialEllen M Apperloo, Jose L Gorriz, Maria Jose Soler, et al.
Annals of Internal Medicine|January 9, 2023
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline UpdateSankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2021
The ASCEND-ND trial: study design and participant characteristicsVlado Perkovic, Allison Blackorby, Borut Cizman, et al.
Molecular Genetics and Metabolism|July 19, 2018
European expert consensus statement on therapeutic goals in Fabry diseaseChristoph Wanner, Michael Arad, Ralf Baron, et al.
Kidney International|April 17, 2018
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across EuropeKatharina Brück, Kitty J Jager, Carmine Zoccali, et al.
Kidney International|October 22, 2022
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidencePeter Rossing, M Luiza Caramori, Juliana C N Chan, et al.
JAMA Internal Medicine|April 4, 2022
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical TrialAjay K Singh, Borut Cizman, Kevin Carroll, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 17, 2026
Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART TrialHiddo J L Heerspink, Maria Soler, Jelle M Beernink, et al.
Annals of Internal Medicine|November 9, 2020
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice GuidelineSankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, et al.
Pageof 67

Showing results (611-620 of 666) with videos related to

Sort By:
Pageof 67
Nature Medicine|October 25, 2024
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trialEllen M Apperloo, Jose L Gorriz, Maria Jose Soler, et al.
Annals of Internal Medicine|January 9, 2023
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline UpdateSankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2021
The ASCEND-ND trial: study design and participant characteristicsVlado Perkovic, Allison Blackorby, Borut Cizman, et al.
Molecular Genetics and Metabolism|July 19, 2018
European expert consensus statement on therapeutic goals in Fabry diseaseChristoph Wanner, Michael Arad, Ralf Baron, et al.
Kidney International|April 17, 2018
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across EuropeKatharina Brück, Kitty J Jager, Carmine Zoccali, et al.
Kidney International|October 22, 2022
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidencePeter Rossing, M Luiza Caramori, Juliana C N Chan, et al.
JAMA Internal Medicine|April 4, 2022
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical TrialAjay K Singh, Borut Cizman, Kevin Carroll, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 17, 2026
Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART TrialHiddo J L Heerspink, Maria Soler, Jelle M Beernink, et al.
Annals of Internal Medicine|November 9, 2020
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice GuidelineSankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, et al.
Pageof 67